Stephen George Dilly, See Remarks at Aimmune Therapeutics, Inc. (AIMT), sold 65,352 shares at $31.84 ($2.1M) on 2018-06-04, disclosed to the SEC on 2018-06-05.
Open-market sale of $2.1M AIMT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.84 | 62,740 | $2.0M | 95.9% |
| 2 | $32.74 | 2,612 | $86K | 4.1% |
| Total | $31.88 avg | 65,352 | $2.1M | 100% |
| Filing → |
| SRRA | BUY | 2021-05-20 | $178K | — | Filing → |
| SGMO | SELL | 2020-03-20 | $210K | — | Filing → |
| SGMO | SELL | 2020-03-18 | $90K | — | Filing → |